MUMBAI, India, July 13 -- Intellectual Property India has published a patent application (202441022114 A) filed by Dr. Mohan'S Healthcare Products Private Limited on March 22, 2024, for Ai-Driven Precision Approach For Individual Subtype (stratification), Risk Prediction And Treatment In Asian Diabetes Population.
Inventors include Dr. Ranjit Mohan Anjana; Dr. Viswanathan Mohan; and Dr. Viswanathan Baskar.
The application for the patent was published on July 10, 2026, under issue no. 28/2026.
Abstract: ABSTRACT AI-DRIVEN PRECISION APPROACH FOR INDIVIDUAL SUBTYPE (STRATIFICATION), RISK PREDICTION AND TREATMENT IN ASIAN DIABETES POPULATION 5 The present invention discloses a method and electronic device (100) for determining diabetes subtypes in an individual by an electronic device. The method includes obtaining a set of diabetes biomarkers from the individual. The set of diabetes biomarkers is then input into an Artificial Intelligence (AI) model. Using the set of diabetes biomarkers, the AI model classifies the individual into one of the 10 diabetes subtypes. Further, the method includes displaying the diabetes subtype of the individual
Disclaimer: Curated by HT Syndication.
